pamidronate has been researched along with methotrexate in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (52.38) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
| Toussirot, E; Wendling, D | 2 |
| Balmaceda, C; Mansukhani, M; Mears, JG; Orazi, A; Rescigno, J; Savage, DG; Shendrik, I | 1 |
| El Maghraoui, A | 1 |
| Ahmad, I; Garg, S; Kapoor, S; Malaviya, AN; Raja, RR | 1 |
| Chakravarty, A; Chogle, AR; Mishra, H | 1 |
| Andersen, J; Bergh, J; Bjerregaard, B; Cold, S; Edlund, P; Ejlertsen, B; Ewertz, M; Jensen, MB; Kamby, C; Kristensen, B; Lindman, H; Mouridsen, HT; Nordenskjöld, B | 1 |
| Goh, L; Samanta, A | 1 |
| Abramson, SJ; Bartolotta, R; Chou, A; Hwang, S; Katz, DS; Meyers, P; Price, AP | 1 |
| Moeckel, GW; Perazella, MA | 1 |
| Abramson, SJ; Chou, AJ; Gorlick, R; Healey, JH; Kellick, MG; Laquaglia, MP; Merola, PR; Meyers, PA; Morris, CD; Wexler, LH | 1 |
| Kim, HS; Kim, YS; Lee, J | 1 |
| Bing, X; Ferguson, PJ; Gopalakrishna, DB; Rao, AP | 1 |
| Chikova, IA; Isupova, EA; Kopchak, OL; Kostik, MM; Mushkin, AY | 1 |
7 review(s) available for pamidronate and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic advances in ankylosing spondylitis.
Topics: Cyclooxygenase Inhibitors; Diphosphonates; Humans; Methotrexate; Pamidronate; Spondylitis, Ankylosing; Thalidomide; Tumor Necrosis Factor-alpha | 2001 |
Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Combined Modality Therapy; Dexamethasone; Diphosphonates; Doxorubicin; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Interleukin-2; Melphalan; Meninges; Methotrexate; Multiple Myeloma; Neoplastic Stem Cells; Osteolysis; Pamidronate; Paraparesis; Recurrence; Salvage Therapy; Seizures; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2002 |
Recent progress in ankylosing spondylitis treatment.
Topics: Celecoxib; Controlled Clinical Trials as Topic; Diphosphonates; Drug Therapy; Humans; Methotrexate; Pamidronate; Pyrazoles; Spondylitis, Ankylosing; Sulfonamides; Tumor Necrosis Factor-alpha | 2003 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Reactive; Behcet Syndrome; Diagnosis, Differential; Diphosphonates; Humans; Immunosuppressive Agents; Lung; Methotrexate; Pamidronate; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Thalidomide; Tomography, X-Ray Computed | 2004 |
A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.
Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diphosphonates; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Meta-Analysis as Topic; Methotrexate; Multicenter Studies as Topic; Pamidronate; Randomized Controlled Trials as Topic; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Steroids; Sulfasalazine; Tumor Necrosis Factor-alpha | 2009 |
Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Diphosphonates; Humans; Ifosfamide; Kidney Glomerulus; Kidney Tubules; Methotrexate; Pamidronate; Renal Insufficiency, Chronic; Risk Factors | 2010 |
3 trial(s) available for pamidronate and methotrexate
| Article | Year |
|---|---|
A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
Topics: Adolescent; Adult; Antirheumatic Agents; Bone Density Conservation Agents; Diphosphonates; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged; Pamidronate; Spondylitis, Ankylosing; Sulfasalazine | 2007 |
Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Pamidronate | 2008 |
Addition of pamidronate to chemotherapy for the treatment of osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Diphosphonates; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Methotrexate; Osteosarcoma; Pamidronate | 2011 |
11 other study(ies) available for pamidronate and methotrexate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[Two bedridden patients with bone metastases from breast cancer effectively treated with pamidronate therapy].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Female; Fluorouracil; Humans; Mastectomy; Methotrexate; Middle Aged; Pamidronate | 2000 |
A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antirheumatic Agents; Diphosphonates; Humans; Methotrexate; Methylprednisolone; Pamidronate; Spondylitis, Ankylosing; Sulfasalazine; Treatment Failure; Tumor Necrosis Factor-alpha | 2007 |
Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Cisplatin; Diphosphonates; Doxorubicin; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Osteosarcoma; Pamidronate; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Sternocostal involvement in chronic recurrent multifocal osteomyelitis associated with ulcerative colitis.
Topics: Adult; Bone Density Conservation Agents; Colitis, Ulcerative; Diphosphonates; Drug Therapy, Combination; Humans; Male; Methotrexate; Osteomyelitis; Pamidronate; Recurrence; Treatment Outcome | 2013 |
Phenotypic Variability in Majeed Syndrome.
Topics: Adolescent; Anemia, Dyserythropoietic, Congenital; Arthritis, Juvenile; Diphosphonates; Follow-Up Studies; Genetic Predisposition to Disease; Genetic Variation; Homozygote; Humans; Immunologic Deficiency Syndromes; Magnetic Resonance Imaging; Male; Methotrexate; Mutation; Nuclear Proteins; Osteomyelitis; Pamidronate; Pedigree; Phenotype; Positron-Emission Tomography | 2016 |
Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Osteomyelitis; Pamidronate; Practice Patterns, Physicians'; Sulfasalazine; Treatment Outcome | 2019 |